REGN · Regeneron Pharmaceuticals
Latest news, signals, and AI analysis for Regeneron Pharmaceuticals (REGN) on Catalayer. Updated continuously as stories are indexed across our news feed.
Recent REGN News
Regeneron (REGN) Enters $2.32B Collaboration With Parabilis to Target ‘Undruggable’ Proteins
Related Tickers
$JNJ · Johnson & Johnson$LLY · Eli Lilly$PFE · Pfizer$MRK · Merck$ABBV · AbbVie$NVO · Novo NordiskFrequently Asked Questions
What sector does REGN belong to?
REGN (Regeneron Pharmaceuticals) is classified under the Pharma sector on Catalayer. You can browse all news in this sector at /sector/pharma.
Where can I track real-time REGN news?
Catalayer aggregates REGN coverage from Reuters, Bloomberg, CNBC, MarketWatch, Yahoo Finance, Seeking Alpha, Barron’s, WSJ, Motley Fool, Benzinga, TipRanks and 20+ other sources. View the live feed at https://catalayer.com/stocks/REGN.
How fast are REGN news alerts on Catalayer?
News is polled every 30–60 seconds. REGN-related stories appear in your workspace within minutes of publication, and you can create a custom monitor to get instant alerts.
Does Catalayer provide AI analysis for REGN?
Yes. The Market Intelligence tier adds AI-powered event classification (monetary policy, earnings, guidance, M&A), directional impact (bullish/bearish), magnitude, and affected-sector analysis to every REGN story.
Is REGN covered in any Catalayer signal channels?
Signal channels and custom keyword monitors both support REGN. Free accounts get 1 monitor; Plus ($29/mo) unlocks 5 monitors with boolean rules across tickers, sectors, and topics.